BioSpace News Archive

Agreement gives law enforcement access to the most advanced handheld tools to help detect drug and alcohol-impaired drivers

The Pilot Program uses the StrainSecure™ technology as a master registry for standardized testing, product verification, and quality assurance.

Atreca, Inc.(Nasdaq: BCEL), a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types, today announced the pricing of its initial public offering of 7,350,000 shares of common stock at a price to the public of $17.00 per share.

During the CAP accreditation process, inspectors perform an on-site inspection and examine the laboratory’s records and quality control of procedures for the preceding two years.

Sunovion Pharmaceuticals Inc. (Sunovion) today announced that the Company has received the 2018 Corporate Responsibility Award and 2018 Corporate Leadership Award from United Way of Tri-County for its positive impact in community service while fostering a culture of Corporate Social Responsibility (CSR)

ARTMS Products Inc., a global leader in the development and commercialization of novel technologies and products that enable cyclotron production of the world’s most needed medical radioisotopes, is pleased to announce they have received $1.5 million funding from Western Economic Diversification Canada as part of its Business Scale-up and Productivity program

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that the Company and its collaborators will present at the 2019 International Congress on Porphyrins and Porphyria (ICPP), being held September 8-11, 2019 in Milan, Italy

Neuropore Therapies, Inc. announced today that it has received orphan drug designation for NPT520-34 for the treatment of amyotrophic lateral sclerosis or ALS.

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced a milestone of 10,000 implants of the Precice® system for conditions related to limb lengthening and reconstruction from NuVasive Specialized Orthopedics™

Innovega Inc. (“Innovega” or the “Company”), a developer of stylish, lightweight, wearable displays that feature a high-resolution, panoramic field of view for medical, consumer, and industrial applications, today highlights the virtual reality (VR) and augmented reality (AR) market opportunity and its eMacula™ product offering